EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 4

Ephedra Ephedra sinica Stapf

Also called: ma huang, Chinese ephedra, ephedrine alkaloids

A low evergreen shrub whose stems and branches contain stimulant ephedrine alkaloids, with a long history of use in China and India. FDA banned the sale of US dietary supplements containing ephedrine alkaloids in 2004.

Category
Botanical
Part used
Stems and branches
Strongest evidence
B Some positive trials
Reviewed
2026-10-28

Class 3 Limited studies in people. A 2003 JAMA meta-analysis found 1 placebo-controlled weight-loss trial of ephedra alone; other trials tested ephedra with caffeine-containing herbs (4) or ephedrine, its main alkaloid, alone (5) or with caffeine (12). No trials of ephedra for athletic performance were found. [4]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

2 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Ephedra does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Ephedra, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Short-term weight loss (pre-2004 research, usually combined with caffeine)BSupplements with ephedrine alkaloids, usually plus caffeine, had modest short-term effects on weight; no studies assessed long-term effects, and NCCIH states the benefit did not outweigh the serious risks. [1]
Athletic performanceCEvidence was insufficient to draw conclusions; almost no new human research has been done since the 2004 ban. [1]

Main constituents: Ephedrine alkaloids (stimulant compounds) [1]

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    See details

    LiverTox (last updated February 10, 2018) gives no likelihood score …

    Details and sources
  • Pregnancy and breastfeeding
    NCCIH: use of ephedra during pregnancy or while breastfeeding is considered unsafe; it is also considered unsafe for children.

    2 statements in the profile.

    Details and sources
  • Interactions with medicines
    5 listed

    Caffeine and other stimulants; CNS stimulants; Monoamine oxidase inhibitors; Digoxin; Theophylline

    Details and sources
  • Cancer evaluations (IARC, NTP)
    1 found

    Each names the exact material tested, which may differ from a supplement.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • Ephedra has been linked to high blood pressure, heart attack, seizure, stroke and psychosis, even at relatively low doses with short-term use, and can be life-threatening or disabling in some people. [1]
  • FDA concluded that ephedrine alkaloids pose short- and long-term risks, mainly through increased blood pressure and sympathomimetic effects on the heart. [2]
  • Other reported side effects: anxiety, dizziness, dry mouth, headache, heartburn, insomnia, irritability, nausea and personality changes. [1]
  • No one can reliably predict who is at greatest risk; people with cardiovascular disease are considered at higher risk of severe harm. Use is considered unsafe in pregnancy, while breastfeeding and in children. [1]
Interactions

Interactions

Known interactions of Ephedra
WithWhat happens
Caffeine and other stimulantsPossible interactions with other stimulants such as caffeine are a theoretical concern. [1]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • The rule names ephedrine-alkaloid sources including Ephedra sinica, E. equisetina, E. intermedia var. tibetica, E. distachya, Sida cordifolia and Pinellia ternata, and their extracts; most North American Ephedra species (such as Mormon tea) lack these alkaloids. [2]
Regulation

Regulatory status

  • US: FDA final rule (Federal Register, February 11, 2004; effective April 12, 2004) declared dietary supplements containing ephedrine alkaloids adulterated under FD&C Act section 402(f)(1)(A), because they present an unreasonable risk of illness or injury. [2]
  • US: codified at 21 CFR 119.1, which states that dietary supplements containing ephedrine alkaloids present an unreasonable risk of illness or injury under recommended or ordinary conditions of use. [3]
  • Scope: the rule covers any supplement containing ephedrine alkaloids regardless of botanical source. It does not cover OTC or prescription drugs, or traditional Asian medicine products not marketed as supplements; FDA said conventional foods with these alkaloids would generally be unsafe food additives. [2]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Ephedrine, pseudoephedrine, methylephedrine and norephedrine (LiverTox: the active ingredient of ma huang appears to be ephedrine and related sympathomimetic alkaloids) Alkaloids (sympathomimetic phenylethylamine alkaloids) [P7]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming ephedra (Ephedra species) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]
  • FDA final rule (Federal Register, February 11, 2004; effective April 12, 2004) declared dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk of illness or injury; the rule covers any botanical source of ephedrine alkaloids. [P8]
  • Codified at 21 CFR 119.1: dietary supplements containing ephedrine alkaloids present an unreasonable risk of illness or injury under recommended or ordinary conditions of use. [P9]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC classification of ephedra or ephedrine alkaloids was found in the IARC Monographs list of classifications (checked 2026-10-29). [P2]
  • NTP TR-307 (May 1986) tested ephedrine sulfate, the purified compound, not ephedra: no evidence of carcinogenicity in F344/N rats or B6C3F1 mice of either sex receiving 125 or 250 ppm in the diet for 2 years. [P10]

Liver (NIH LiverTox)

  • LiverTox (last updated February 10, 2018) gives no likelihood score; it states ephedra preparations have been implicated in more than a dozen instances of clinically apparent acute liver injury, and that it is difficult to say whether injury is due to ephedra itself or a contaminant. [P7]

Interactions with medicines

  • Caffeine and other stimulants: NCCIH notes theoretical reasons to suspect that ephedra might interact with other stimulants like caffeine. [P5]
  • CNS stimulants: MSK: ephedra may increase stimulatory effects. [P6]
  • Monoamine oxidase inhibitors: Concomitant use can cause hypertensive crisis. [P6]
  • Digoxin: Concomitant use can cause arrhythmia. [P6]
  • Theophylline: Ephedra may decrease its effectiveness. [P6]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P3]

Supply and conservation

  • Ephedra sinica: IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29 [P4]

Absorption in people

  • In eight healthy adults given one dose of a supplement labeled to contain 20 mg ephedrine alkaloids and 200 mg caffeine, plasma clearance and elimination half-lives of ephedrine and pseudoephedrine were comparable to published values for drug formulations; mean systolic blood pressure rose by up to 14 mm Hg at 90 minutes. [P11]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • NCCIH: use of ephedra during pregnancy or while breastfeeding is considered unsafe; it is also considered unsafe for children. [P5]
  • MSK: because ephedra can stimulate uterine contraction, women who are pregnant should not consume it. [P6]

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  3. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  4. GBIF species API: IUCN Red List category for Ephedra sinica, 2026-10-29. api.gbif.org
  5. NCCIH. Ephedra (Last Updated: November 2024), 2024-11. nccih.nih.gov
  6. Memorial Sloan Kettering Cancer Center. About Herbs: Ephedra (last updated March 9, 2023), 2023-03-09. mskcc.org
  7. NIH LiverTox (NIDDK). Ephedra (Last Update: February 10, 2018), 2018-02-10. ncbi.nlm.nih.gov
  8. FDA. Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk. Federal Register 69(28), February 11, 2004, 2004-02-11. govinfo.gov
  9. eCFR. 21 CFR 119.1, Dietary supplements containing ephedrine alkaloids (up to date as of 10/09/2026), 2026-10-09. ecfr.gov
  10. National Toxicology Program. TR-307: Toxicology and Carcinogenesis Studies of Ephedrine Sulfate in F344/N Rats and B6C3F1 Mice (Feed Studies), May 1986 (abstract), 1986-05. ntp.niehs.nih.gov
  11. Haller CA, Jacob P, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002;71(6):421-432 (PMID 12087345), 2002-06. pubmed.ncbi.nlm.nih.gov
Sources

Sources

  1. NCCIH. Ephedra (last updated November 2024), 2024-11. nccih.nih.gov
  2. FDA. Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk. Federal Register 69(28), February 11, 2004, 2004-02-11. govinfo.gov
  3. eCFR. 21 CFR 119.1, Dietary supplements containing ephedrine alkaloids (up to date as of 10/09/2026), 2026-10-09. ecfr.gov
  4. Shekelle PG, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003;289(12):1537-45 (PMID 12672771), 2003-03-10. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.